Join Now

Utah Life Sciences News & Events

Bloom Surgical: 2025 Year In Review

January 7, 2026

2025 marked a year of significant progress of reached milestones and successes for Bloom Surgical and our laparoscope wiper and irrigation cleaning system. We’re pleased to share our top 10 accomplishments from the year.

Top Accomplishments:

  1. Raised Pre-Seed Round
    Led by venture capital funds, with participation from angel investors and physicians
  2. Finalized FDA Regulatory Pathway & Strategy
  3. Submitted FDA Pre-Submission
    Covered straight-stick product lineup (5 mm 0°, 30° & 10 mm 0°, 30°)
  4. Optimized Onboard Irrigation and User Ergonomics
  5. Completed Production Equivalent Prototypes
  6. Finalized V&V plan and Commenced V&V Activities
    On track for FDA submission and approval 2026
  7. Onboarded Legal Manufacturer of Record with FDA-Ready QMS
    Partnered with ZIEN Medical Technologies as a scalable manufacturing partner and legal manufacturer of record, with full QMS management onboarded
  8. Secured $200K Non-Dilutive Manufacturing Grant
    Selected by the Utah Governor’s Office of Economic Opportunity to support internal build-out of advanced micro-manufacturing capabilities
  9. Strengthened Intellectual Property
    Filed new patents covering key product features
  10. Expanded Team
    Strengthened leadership, with expanded board, advisory, business development, and R&D capabilities

What to Expect in 2026 

Looking ahead, 2026 will be a year of execution and commercialization. Bloom Surgical enters 2026 in a strong financial position, having achieved a 2025 budget surplus across nearly all categories.

We plan to obtain FDA clearance and launch both the 10 mm and 5 mm 0° configurations in 2026, supported by a growing network of surgeon champions. This will be followed by FDA clearance on the 5 mm 30° configuration, alongside continued development of next-generation, AI-integrated and robotic-compatible versions.

We are deeply grateful for the continued trust and support of our many partners, investors, and advisors as we enter 2026 working together to improve minimally invasive surgery for both patients and physicians.